Omega-3 polyunsaturated fatty acids: a specific liver drug for non-alcoholic fatty liver disease (NAFLD)

Med Hypotheses. 2008 Nov;71(5):820-1. doi: 10.1016/j.mehy.2008.07.008. Epub 2008 Aug 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Biopsy
  • Fatty Acids, Omega-3 / therapeutic use*
  • Fatty Liver / drug therapy*
  • Hepatocytes / metabolism
  • Humans
  • Prognosis
  • Treatment Outcome

Substances

  • Fatty Acids, Omega-3